Literature DB >> 833758

Pharmacokinetics of morphine by radioimmunoassay: the influence of immunochemical factors.

D H Catlin.   

Abstract

Two radioimmunoassays (RIA-A and RIA-B) were used to estimate morphine equivalents (ME) in rabbit serum after i.v. administration of morphine or morphine-3-glucuronide (M-3-G). RIA-A and RIA-B differed only with respect to the particular pool of antibodies used, and both were elicited from rabbits immunized with a 2-diazomorphine-protein conjugate. In vitro inhibition studies indicated the molar ratio of M-3-G/morphine which inhibited 3H-morphine-antimorphine binding by 50% (150) was 90 and 14 for RIA-A and RIA-B, respectively. RIA-B 150 values were dependent on the final protein concentration of the incubation mixture. RIA-A and RIA-B estimates of the ME per milliliter were in agreement in serum samples obtained from rabbits after i.v. morphine 0.01 mg/kg; however, after higher doses only samples obtained in the first minutes agreed and at later times RIA-B estimates exceeded RIA-A by increasing amounts. After i.v. M-3-G (1.0 mg/kg) RIA-B estimated 20 to 25 times more ME per milliliter than RIA-A. After rapid i.v. administration of morphine (1 or 5 mg/kg) the disappearance curves obtained with RIA-B were multiphasic and contained a prolonged terminal phase with an estimated half-life of 24 hours. The higher estimates obtained with RIA-B are best explained by cross-reactions with M-3-G or other morphine metabolites. With RIA-A the mean serum morphine clearance (86 ml/min/kg) and half-life of the elimination phase (74 minutes were independent of dosage. The least complicated pharmacokinetic model which describes the disposition of morphine in the rabbit is the open two-compartment model.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833758

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Indices of dentate gyrus neurogenesis are unaffected immediately after or following withdrawal from morphine self-administration compared to saline self-administering control male rats.

Authors:  Sarah E Bulin; Steven J Simmons; Devon R Richardson; Sarah E Latchney; Hannah M Deutsch; Sanghee Yun; Amelia J Eisch
Journal:  Behav Brain Res       Date:  2019-12-20       Impact factor: 3.332

2.  Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.

Authors:  B Dahlström; A Tamsen; L Paalzow; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

3.  Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites.

Authors:  F J Rowell; R A Seymour; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects.

Authors:  J J Savarese; P D Goldenheim; G B Thomas; R F Kaiko
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.